The global therapeutic drug monitoring market in terms of revenue was estimated to be worth $1.8 billion in 2023 and is poised to reach $2.9 billion by 2030, growing at a CAGR of 9.6% from 2023 to 2030. This market's expansion is being driven mostly by an increased emphasis on research experiments connected with therapeutic medication monitoring and an increase in severe illnesses.
The global fetal monitoring market in terms of revenue was estimated to be worth $3.7 billion in 2023 and is poised to reach $5.2 billion by 2030, growing at a CAGR of 7.3% from 2023 to 2030. A market industry trend analysis is included in the new research study. Industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and market purchasing behaviour are all included in the new study report.
The global endoscopic submucosal dissection market in terms of revenue was estimated to be worth $347 million in 2022 and is poised to reach $483 million by 2027, growing at a CAGR of 6.9% from 2022 to 2027. The increasing incidence of target diseases such as cancer is expected to accelerate the need for endoscopic procedures, which, in turn, will propel the growth of this market in the coming years.
The global dental equipment market in terms of revenue was estimated to be worth $6.5 billion in 2022 and is poised to grow at a CAGR of 6.1% from 2023 to 2030. The new research study includes a market industry trend analysis. The new study report covers industry trends, price analysis, patent analysis, conference and webinar materials, important stakeholders, and market purchasing behavior.
Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!
One of our marquee services We profile relevant start-up companies in the market.
Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.
Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.